RO-28-1675 (50 mg/kg; po) reduces blood glucose levels in wild-type C57BL/6J mice.
RO-28-1675 (10 mg/kg; po) displays lower clearance and higher oral bioavailability.
| Animal Model: | 10 weeks old male C57BL/6J mice |
| Dosage: | 50 mg/kg |
| Administration: | Oral administration |
| Result: | Reduced blood glucose levels. |
| Animal Model: | C57BL/6J mice |
| Dosage: | 10 mg/kg |
| Administration: | Oral administr ation |
| Result: | AUC 0-inf (5150 ng? h/mL), C max (1140 μg/mL) , T max (3.3 hours ), F po (92.8%) with 10 mg/kg orally administered. |
![(2R)-3-Cyclopentyl-2-[4-(methanesulfonyl)phenyl]-N-(thiazol-2-yl)propionamide Structure](/CAS2/GIF/300353-13-3.gif)